BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2020
View Archived Issues
PDAC subtypes point to targeting strategies
Read More
Natural killer cells dabble in adaptive immunity
Read More
Novel inhaled therapy shows efficacy in preclinical models of SARS-CoV-2 virus infection
Read More
FDA grants approval to initiate COVID-19 study of EB-05
Read More
First patient dosed in phase IIa study of ATI-1777
Read More
European researchers patent new compounds for epilepsy
Read More
AstraZeneca discloses new PROTACs for cancer therapy
Read More
Protecting telomeres prevents lung fibrosis
Read More
First-in-human data presented for ASP-5354
Read More
Chiesi Farmaceutici identifies PI3K inhibitors
Read More
New IRAK-4 inhibitors synthesized by Galapagos
Read More
University of Pennsylvania divulges new CAR T cells for cancer
Read More
Apellis reports 18-month data on pegcetacoplan in advanced geographic atrophy
Read More
Second phase II study of Lyme disease vaccine candidate VLA-15 meets endpoints
Read More
Cardiff Oncology reports phase II results with onvansertib in mCRPC
Read More
Amicus presents interim phase I/II data for AT-GTX-501 gene therapy
Read More
COMPneo predicts carotid artery stenosis
Read More
PRISM3 study of CP-101 oral microbiome drug shows it prevents CDI recurrence
Read More
Phase IIb study in Japan of KW-6356 for Parkinson's disease meets primary endpoint
Read More
FDA grants full approval to Venclexta combinations for newly diagnosed AML
Read More
Union to explore use of UNI-91103 to prevent COVID-19
Read More
Nascent reports in vitro data on pritumumab for COVID-19
Read More
CRISPR Therapeutics reports topline phase I data on CTX-110 for relapsed or refractory NHL
Read More
IntraBio reports further data on IB-1001 for Niemann-Pick disease type C
Read More
Phase III data reported on Merck & Co.'s 15-valent pneumococcal conjugate vaccine V-114
Read More
